For example, oleoylethanolamide, an endogenous PPAR-α agonist, was significantly high level in the plasma of chronic lymphocytic leukemia patients such that its plasma concentration was directionally related to the number of circulating leukemic cells [29]. This evidence concerns the gene PPARA and B-cell chronic lymphocytic leukemia.